SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-055647
Filing Date
2024-05-08
Accepted
2024-05-08 16:10:16
Documents
12
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acad-20240508.htm   iXBRL 8-K 40324
2 EX-99.1 acad-ex99_1.htm EX-99.1 164488
  Complete submission text file 0000950170-24-055647.txt   330812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20240508.xsd EX-101.SCH 25052
15 EXTRACTED XBRL INSTANCE DOCUMENT acad-20240508_htm.xml XML 4760
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 24926099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)